A detailed history of Keybank National Association transactions in Zoetis Inc. stock. As of the latest transaction made, Keybank National Association holds 257,545 shares of ZTS stock, worth $50.3 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
257,545
Previous 270,699 4.86%
Holding current value
$50.3 Million
Previous $45.8 Million 2.52%
% of portfolio
0.18%
Previous 0.19%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$145.54 - $178.83 $1.91 Million - $2.35 Million
-13,154 Reduced 4.86%
257,545 $44.6 Million
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $1.72 Million - $2.08 Million
-10,389 Reduced 3.7%
270,699 $45.8 Million
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $3 Million - $3.96 Million
-19,800 Reduced 6.58%
281,088 $55.5 Million
Q3 2023

Nov 08, 2023

SELL
$167.14 - $192.77 $2.82 Million - $3.26 Million
-16,891 Reduced 5.32%
300,888 $52.3 Million
Q2 2023

Aug 01, 2023

SELL
$160.94 - $186.23 $9.17 Million - $10.6 Million
-56,978 Reduced 15.2%
317,779 $54.7 Million
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $8.53 Million - $10.3 Million
-58,653 Reduced 13.53%
374,757 $62.4 Million
Q4 2022

Jan 31, 2023

SELL
$131.14 - $157.47 $6.77 Million - $8.13 Million
-51,634 Reduced 10.65%
433,410 $63.5 Million
Q3 2022

Oct 27, 2022

SELL
$148.29 - $182.55 $1.72 Million - $2.12 Million
-11,590 Reduced 2.33%
485,044 $71.9 Million
Q2 2022

Aug 08, 2022

SELL
$155.97 - $200.09 $7.11 Million - $9.12 Million
-45,555 Reduced 8.4%
496,634 $85.4 Million
Q1 2022

Apr 28, 2022

BUY
$181.39 - $234.03 $3.21 Million - $4.14 Million
17,689 Added 3.37%
542,189 $102 Million
Q4 2021

Feb 07, 2022

BUY
$193.69 - $247.03 $1.85 Million - $2.35 Million
9,530 Added 1.85%
524,500 $128 Million
Q3 2021

Nov 08, 2021

BUY
$189.29 - $209.69 $1.82 Million - $2.01 Million
9,601 Added 1.9%
514,970 $100 Million
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $1.31 Million - $1.58 Million
8,431 Added 1.7%
505,369 $94.2 Million
Q1 2021

May 07, 2021

BUY
$144.0 - $169.39 $1.54 Million - $1.81 Million
10,662 Added 2.19%
496,938 $78.3 Million
Q4 2020

Feb 09, 2021

SELL
$157.07 - $174.35 $456,916 - $507,184
-2,909 Reduced 0.59%
486,276 $80.5 Million
Q3 2020

Oct 29, 2020

BUY
$137.1 - $165.37 $1.28 Million - $1.54 Million
9,307 Added 1.94%
489,185 $80.9 Million
Q2 2020

Aug 10, 2020

BUY
$111.92 - $142.53 $2.24 Million - $2.85 Million
20,015 Added 4.35%
479,878 $65.8 Million
Q1 2020

May 13, 2020

BUY
$92.66 - $144.94 $782,884 - $1.22 Million
8,449 Added 1.87%
459,863 $54.1 Million
Q4 2019

Feb 05, 2020

BUY
$116.25 - $133.25 $486,506 - $557,651
4,185 Added 0.94%
451,414 $59.7 Million
Q3 2019

Nov 04, 2019

BUY
$112.57 - $128.43 $2.12 Million - $2.42 Million
18,857 Added 4.4%
447,229 $55.7 Million
Q2 2019

Aug 01, 2019

BUY
$97.98 - $114.28 $3.38 Million - $3.94 Million
34,502 Added 8.76%
428,372 $48.6 Million
Q1 2019

May 08, 2019

BUY
$81.56 - $100.67 $4.75 Million - $5.86 Million
58,198 Added 17.34%
393,870 $39.7 Million
Q4 2018

Jan 30, 2019

BUY
$79.28 - $95.27 $5.63 Million - $6.77 Million
71,031 Added 26.84%
335,672 $28.7 Million
Q3 2018

Nov 08, 2018

BUY
$83.5 - $93.23 $5.42 Million - $6.05 Million
64,868 Added 32.47%
264,641 $24.2 Million
Q2 2018

Aug 08, 2018

BUY
$79.9 - $89.2 $10.3 Million - $11.5 Million
128,634 Added 180.82%
199,773 $17 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $4.56 Million - $5.4 Million
63,819 Added 871.84%
71,139 $5.94 Million
Q4 2017

Feb 08, 2018

SELL
$63.24 - $72.8 $428,134 - $492,856
-6,770 Reduced 48.05%
7,320 $527,000
Q3 2017

Nov 02, 2017

SELL
$59.73 - $65.4 $32,552 - $35,643
-545 Reduced 3.72%
14,090 $898,000
Q2 2017

May 14, 2018

BUY
N/A
419 Added 2.95%
14,635 $913,000
Q1 2017

May 14, 2018

SELL
N/A
-5,322 Reduced 27.24%
14,216 $759,000
Q4 2016

May 14, 2018

BUY
N/A
19,538
19,538 $1.05 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $91.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.